US Patent 7455984 Immunoreactive and immunotherapeutic molecules
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Andrew Lew0
George Rudy0
Leonard Harrison0
Margo Honeyman0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+462 characters)
Article
Patent abstract
The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with antibodies or T-cells in subjects having pre-clinical or clinical Insulin-Dependent Diabetes Mellitus (IDDM). These molecules are preferentially immunoreactive to T-cells in subjects having pre-clinical or clinical IDDM and are useful in the development of diagnostic, therapeutic and prophylactic agents for IDDM.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07455984 Immunoreactive and immunotherapeutic molecules US Patent 7455984 Immunoreactive and immunotherapeutic molecules
Infobox
Patent Number
074559840
Patent Number
74559840
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
074559840
Date of Patent
November 25, 2008
0Patent Application Number
100408150
Date Filed
January 7, 2002
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07455984 Immunoreactive and immunotherapeutic molecules
Infobox
Is a
Patent jurisdiction
Patent number
07455984
Date of patent
November 25, 2008
Patent application number
10040815
Date Filed
January 7, 2002
Patent primary examiner
Find more entities like US Patent 7455984 Immunoreactive and immunotherapeutic molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
